Evaluation of the Effect of Virtual Reality on Pain in the Management of Chronic Wounds. (DouReV)

Evaluation of the Effect of Virtual Reality on Pain in the Management of Chronic Wounds: Multicentric Randomized Controlled Trial.

Pain management is a priority axis of health insurance spending objectives and contributes to improving the quality of care.There are several types of pain: acute, chronic and induced. These are often found in the management of chronic wounds. The high prevalence of chronic wounds represents a major public health problem. Chronic wounds require long, painful and regular treatment. When dressing these wounds, pain management is essential. Indeed, it can generate healing delays. Usually, pharmacological methods are used to reduce the pain induced by care. But these methods can lead to undesirable effects. Thus, new non-pharmacological techniques are emerging.The investigators therefore wish to assess the effect of virtual reality on pain induced by care during the repair of dressings in the management of chronic wounds.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limoges, France, 87042
        • Centre Hospitalier Universitaire de Limoges
        • Principal Investigator:
          • Camille DUPRAT, Nurse
      • Saint-Pierre, France, 97410
        • Centre hospitalier universitaire de la Réunion
        • Principal Investigator:
          • Julien MAILLOT, Nurse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults
  • Knowing how to read and write French
  • Able to understand the issues of the study and give consent
  • Carrier of a chronic wound (ulcers, bedsores or wounds of the diabetic foot)
  • Requiring a weekly dressing treatment in the department for at least 4 successive treatments(4 weeks)
  • With pain during pre-inclusion care at least ≥3 to the Visual Analog Scale
  • Person with cognitive and sensory capacities adapted to Virtual Reality (pre-inclusion verification on a device test of 5 to 10 minutes)
  • Person affiliated or beneficiary of a social security scheme

Exclusion Criteria:

  • Carriers of a wound located on the face or end of the head and interfering with the proper use of the Virtual Reality mask
  • Visually impaired and / or hard of hearing impacting the correct use of the Virtual Reality mask (test of 5 to 10 minutes of the device during the pre-inclusion visit)
  • Patient not fluent in French.
  • Current diagnosis of epilepsy, dementia or other neurological diseases preventing the use of Virtual Reality hardware and software
  • Patients under guardianship or curators

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Classic protocol for pain management
classic protocol for pain management during chronic wound dressing
EXPERIMENTAL: Virtual reality for pain management
protocol associating virtual reality with the classic protocol for pain management during the treatment of chronic wound dressings
Use of a virtual reality headset while caring for chronic wound dressings

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment-induced pain
Time Frame: 4 weeks
(AVS) Analog Visual Scale 0 to 10 : 0 for no pain ; 10 for maximum pain imaginable
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Level of situational anxiety
Time Frame: 4 weeks
(STAI-Y-A) State-Trait Anxiety Scale - Overall score varies between 20 and 80. The higher the score, the more anxious the patient.
4 weeks
Duration of treatment
Time Frame: 4 weeks
time in seconds
4 weeks
Worse Treatment-induced pain
Time Frame: 4 weeks
Analog Visual Scale
4 weeks
Frequency of use of analgesic
Time Frame: 4 weeks
analgesic consumption
4 weeks
Time spent thinking about pain
Time Frame: 4 weeks
(AVS) Analog Visual Scale 0 to 10 : 0 for no thought of pain ; 10 for throughout the treatment
4 weeks
Healing process
Time Frame: 4 weeks
measurement of the wound on photograhies by imageJ ® planimetry software
4 weeks
Medical Outcome Study Short Form
Time Frame: 4 weeks
(SF6) Short Form (36) Health Survey_ Quality of life questionnaire
4 weeks
Tolerance of virtual reality
Time Frame: 4 weeks
frequency of occurrence and intensity of motion sickness events
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

September 1, 2020

Primary Completion (ANTICIPATED)

March 1, 2022

Study Completion (ANTICIPATED)

May 1, 2022

Study Registration Dates

First Submitted

May 22, 2020

First Submitted That Met QC Criteria

May 28, 2020

First Posted (ACTUAL)

June 2, 2020

Study Record Updates

Last Update Posted (ACTUAL)

June 2, 2020

Last Update Submitted That Met QC Criteria

May 28, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2019/CHU/12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Wounds

Clinical Trials on virtual reality

3
Subscribe